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Increased intrarenal renin-angiotensin system activity contributes to
diabetic nephropathy. ANG II generation in mesangial cells (MC) is
increased by high-glucose (HG) exposure. This study assessed the
mechanisms involved in the glucose-induced ANG II generation in rat
MC. Under basal conditions, MC mainly secreted prorenin. HG
decreased prorenin secretion and induced a striking 30-fold increase
in intracellular renin activity. After 72 h of HG exposure, only the
mRNA levels for angiotensinogen and angiotensin-converting en-
zyme (ACE) were significantly elevated. However, after shorter
periods of 24 h of HG stimulation the mRNA levels of the enzymes
prorenin and cathepsin B, besides that for ACE, were significantly
increased. The results suggest that the HG-induced increase in ANG
II generation in MC results from an increase in intracellular renin
activity mediated by at least three factors: a time-dependent stimula-
tion of (pro)renin gene transcription, a reduction in prorenin enzyme
secretion, and an increased rate of conversion of prorenin to active
renin, probably mediated by cathepsin B. The increase in angio-
tensinogen mRNA in parallel to increased renin activity indicates that
HG also increased the availability of the renin substrate. The consis-
tent upregulation of ACE mRNA suggests that, besides renin, ACE is
directly involved in the increased mesangial ANG II generation
induced by HG.
hyperglycemia; diabetic nephropathy; glomerular sclerosis; renin-
angiotensin system
DIABETIC NEPHROPATHY IS CHARACTERIZED by excessive produc-
tion of mesangial matrix that contributes to glomerular sclero-
sis, leading to proteinuria and renal failure. Among the poten-
tial mediators of mesangial matrix expansion in diabetic ne-
phropathy, the peptide ANG II is particularly outstanding, and
many lines of evidence suggest activation of the intrarenal
renin-angiotensin system (RAS) in diabetes (21). The RAS has
been extensively studied in diabetes, and strong evidence
indicates that the inhibition of angiotensin-converting enzyme
(ACE) and/or ANG II receptors delays the progression of
diabetic nephropathy (3, 37). Despite these benefits, the reno-
protective effects of RAS inhibition cannot be fully explained
only by the hemodynamic effects of the system causing a
reduction in blood pressure. Moreover, many patients with
diabetic nephropathy paradoxically present low plasma renin
activity (12, 32). Thus renin suppression in this condition
supports the hypothesis that, rather than systemic synthesis,
increased local synthesis of ANG II in the kidney may con-
tribute to the pathogenesis of diabetic nephropathy, although
the specific site of intrarenal ANG II in this pathological
condition is not completely known.
Renal tubular epithelial cells constitute a potential site of
intrarenal ANG II synthesis (25, 35). In addition, it has been
demonstrated that mesangial cells express mRNA for renin,
angiotensinogen, and ACE (4, 5). Renin is a rate-limiting
enzyme in the synthesis of ANG II (34), and we have recently
demonstrated that mesangial cells in culture are able to syn-
thesize, store, and secrete both forms of the enzyme, i.e., active
renin and inactive prorenin (4).
Hyperglycemia has been recognized to be the pathogenic
factor of the long-term complications of diabetes mellitus.
Thus in the present study we examined whether a high glucose
concentration in the culture medium is able to modify renin
synthesis, the secretion of the renin/prorenin ratio, and the
intracellular renin activity in mesangial cells in culture. Also,
we examined whether this “hyperglycemic” condition alters
the levels of mRNA expression of RAS components, including
angiotensinogen, prorenin, ACE, types I and II (AT1 and AT2)
angiotensin receptors, and cathepsin B, a potential enzyme
involved in renin activation. Finally, we also determined
whether glucose-inducing modifications in renin activity and in
the expression of RAS components result in an increase in
local ANG II generation.
MATERIALS AND METHODS
Primary culture of rat mesangial cells. Mesangial cells were
cultured by standard techniques using glomerular isolation by differ-
ential sieving (17). Briefly, glomerular mesangial cells were cultured
from kidneys freshly removed from normal adult male Wistar rats.
The kidney cortex was macrodissected, fragmented, forced through a
graded series of stainless steel sieves (60, 100, and 200 mesh), and
rinsed with RPMI 1640 culture medium. The glomeruli were then
collected from the surface of the third sieve and forced through a 25
7-gauge needle for full decapsulation. Mesangial cells were obtained
from collagenase-treated, isolated glomeruli to remove the epithelial
cell component. Glomeruli were plated at a density of 300 glomer-
uli/cm onto RPMI 1640 containing 10 mM D-glucose and supple-
mented with 20% fetal calf serum, 50 U/ml penicillin, 2.6 g acid
HEPES, and 2 mM glutamine. Culture flasks were kept in a 95%
air-5% CO2 humidified environment at 37°C. The culture medium
was replaced every 36 h. After 3 wk, cells were harvested with trypsin
and the subcultures were grown in the same culture medium. Cells
were used between the third and fifth subculture and characterized by
classic methods using the following criteria: morphological appear-
ance of stellate cells, immunofluorescence staining of the extracellular
matrix for type IV collagen and fibronectin, negative immunofluores-
cence staining for human factor VIII antigens (glomerular endothelial
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cells) and cytokeratin (parietal epithelial cells), and positive immu-
nofluorescence staining for actin and myosin. In particular, the pres-
ence of contaminating juxtaglomerular cells was excluded on the basis
of their characteristic phenotype including their spherical shape and
the presence of a high density of granules.
Experimental protocol. At subconfluence, mesangial cells were
divided into three groups as follows: control, where cells were kept in
RPMI 1640 medium supplemented with FBS, containing normal
glucose concentration of 10 mM D-glucose (NG group); high glucose,
where cells were cultured in RPMI 1640 supplemented with FBS
containing 30 mM D-glucose (HG group); and mannitol, where cells
were submitted to the same procedure as used for the cell culture in
the presence of glucose, but 30 mM mannitol was added instead of
glucose and served as osmolarity control (M group). Cells were
exposed to 30 mM D-glucose or mannitol for a total of 72 h (16). After
48 h, cells were rinsed twice with PBS and the culture medium was
replaced with a medium containing the respective normal- or high-
glucose and mannitol concentrations, but no FBS, to keep the cells in
the G0 phase of the cell cycle and without any interference from serum
proteins. The culture medium was then collected over the last 24 h and
stored at 70°C until use. Cells were rinsed with PBS, lysed with 1
mM TrisHCl buffer, pH 7.5, and stored at 70°C until use. An
additional group of cells were exposed to high glucose concentration
for a shorter period of 24 h.
Determination of active and inactive renin (prorenin) content and
renin activity. The renin content of the active and inactive forms of
renin was estimated by measuring the amount of ANG I present in the
cell lysate and culture medium by HPLC, as described below. Total
renin content included active renin and the inactive prorenin forms.
Prorenin was activated by adding 10 l of trypsin (50 g/ml) for
16–18 h at 37°C to both the cell lysate and culture medium. Active
renin was evaluated in the absence of trypsin. To prevent further
cleavage of prorenin, angiotensinogen, and ANG I, a pool of enzy-
matic inhibitors was added to the cell homogenate and culture me-
dium: 50 mM EDTA, 1 mM OPhe, 32 mM PMFS, and 200 mM DTT.
These inhibitors act efficiently on a broad range of metallo-, serine,
and cysteine proteases, respectively. Renin activity was estimated by
ANG I generation when the cell lysate and culture medium (in the
presence and absence of trypsin) were incubated with 10 l of 1
mg/ml synthetic tetradecapeptide substrate (Sigma, St. Louis, MO) for
4 h at 37°C, as previously described (24). The reaction was stopped by
adding 10 l of 50% H3PO4. One hundred microliters of each sample
were filtered and injected into the HPLC system. The released ANG
I peptide was quantified by reverse-phase HPLC using an aquapore
ODS 300 column equilibrated with 0.1% phosphoric acid containing
5% acetonitrile (vol/vol). ANG I was separated by isocratic elution for
5 min, followed by a 20-min linear gradient of 5–35% acetonitrile in
0.1% phosphoric acid (vol/vol) at 1.5 ml/min. The chromatographic
profile of each sample was compared with that obtained for standard
samples containing angiotensinogen and ANG I at an absorbance of
214 nm. Peptide fragments were identified by elution position and
quantified by integration area using repeated injections of standard
peptide solution to correct for small differences in retention time
(6%) and peak height (5%). The results were corrected by the
amount of intracellular protein determined by the method of Lowry.
All reagents used for renin analysis were purchased from Sigma.
Identification of RAS component mRNA expression by RT-PCR.
The expression of mRNAs of the RAS components in mesangial cells
was determined by RT-PCR. Total RNA was purified from cells by
the phenol and guanidine isothiocyanate-cesium chloride method
using an appropriate kit (TRIzol, Life Tecnologies). The RNA pellet
was resuspended in RNase-free water. Total RNA concentration was
estimated with a spectrophotometer (Gene Quant RNA/DNA calcu-
lator, Amersham Pharmacia Biotech, Uppsala, Sweden). Two micro-
grams of total RNA were reverse transcribed into cDNA by the
addition of a mix containing 0.5 mg/ml oligo dT, 10 mM DTT, 0.5
mM dNTPs (Pharmacia Biotech), and 200 U of RT enzyme (Super-
Script RT, GIBCO BRL). The mixture was incubated at 37°C for 1 h
and then at 95°C for 5 min. PCR was performed in a thermal cycler
(model PTC-100, MJ Research, Watertown, MA) using 2 l of
reverse-transcribed cDNA in a total volume of 20 l containing
1.0–2.5 mM MgCl (optimized for each primer pair), 0.5 mM of each
primer, 0.5 mM dNTP mix, and 0.5 U Taq DNA polymerase (Phar-
macia Biotech). Primer sequences for amplification of angiotensino-
gen, prorenin, ACE, and AT1 and AT2 receptors were designed using
appropriate software (PCR-Designer, Research Genetics) based on
each cDNA sequence obtained from GenBank. Primer sequences and
the amplification conditions for each primer are shown in Table 1.
Negative controls were included in each PCR set where cDNA was
replaced with water as a control for contamination from exogenous
sources. In addition, the RT enzyme was omitted in some samples as
a negative control for amplification of genomic DNA. Positive con-
trols included kidney cortex cDNA and the efficiency of the RT
reaction was monitored by the amplification of the constitutively
expressed gene for -actin. PCR products were electrophoresed on
1% agarose gels and visualized by ethidium bromide staining under
UV light.
Expression levels of RAS components by quantitative real-time
PCR analysis. Because the presence of RAS components was con-
firmed by RT-PCR, the expression levels of each mRNA were
estimated by real-time RT-PCR using a GeneAmp 5700 Sequence
Detection System SDS (ABI Prism 7700, Applied Biosystems), which
was developed to determine gene expression with high sensitivity and
specificity. The cDNA was synthesized from 1 g of total RNA
extracted from each group of cells as described above. Real-time PCR
product accumulation was monitored using the intercalating dye
SYBR Green I (Molecular Probes), which exhibits a higher fluores-
cence on the binding of double-strand DNA. Relative gene expression
was calculated using conditions at the early stages of PCR, when
amplification was logarithmic and thus could be correlated to the
initial copy number of gene transcripts. The reactions were cycled 40
times under the conditions previously determined by conventional
PCR. Fluorescence for each cycle was quantitatively analyzed by ABI
Prism 7700 SDS (Applied Biosystems). At the end of the PCR, the
temperature was increased from 60 to 95°C at a rate of 2°C/min, and
fluorescence was measured every 15 s to construct the melting curve.
A nontemplate control was run with each assay. The relative amount
of each mRNA was estimated using a standard curve constructed from
serial dilutions of cDNA including 1:1, 1:10, and 1:100. The results of
five experiments per group are reported as relative expression nor-
malized with the GAPDH housekeeping gene, used as an endogenous
control, and expressed in arbitrary units.
ANG II measurement by ELISA. ANG II levels in the cell lysate
were determined by ELISA using the avidin-streptavidin method as
previously described (38). Five micrograms of protein samples were
Table 1. PCR primer sequences and product size
Molecule Primer Sequence
Product
Size, bp
Angiotensinogen 5-TCCCTGTCCTGTAATCCCTC-3 398
5-GGCTGCTGCTCATCATTTAT-3
Prorenin 5-AAGGTTTCCTCAGCCAAGAT-3 295
5-AAGTTGCCCTGGTAATGTTG-3
ACE 5-GCAGAACTTCACTGACCAAAAG-3 228
5-TCAAAGGAGGGGGACTCATA-3
AT1B receptor 5-ATGCCAGTGTGTTTCTGCTC-3 244
5-CCAATGGGGAGTGTTGAGTT-3
AT2 receptor 5-GTGTCCAGCATTTACATCTTCA-3 275
5-CACCAAACAAGGGGAACTAC-3
Cathepsin B 5-GGGGGAAATCTACAAAAATG-3 388
5-AAAGACTCCTATCTGCCTCACT-3
ACE, angiotensin-converting enzyme.
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added to the wells of a microtiter plate in duplicate. Protein was
allowed to adsorb for 1 h at 37°C and then blocked with 200 l of
PBS-Tween 20 containing 0.5% casein for 2 h at 37°C, and the
anti-ANG II antibody (1:100 dilution) was added to the respective
well and incubated for 1.5 h at 37°C. Plates were washed three times
with PBS-Tween 20, and 150 l of biotinylated anti-mouse IgG
(1:500 dilution, Life Science) were added to each well and incubated
for 1 h at 37°C. Samples were washed and then incubated with 100 l
of streptavidin-peroxidase (1:2,000 dilution, Amersham Life Science)
for 45 min at 37°C. The final wash was followed by development
using o-phenylenedimine dihydrochloride (Abbott Laboratories) and
hydrogen peroxidase reagents for 20 min at room temperature. Ab-
sorbance was recorded at 495 nm, and ANG II concentrations were
calculated from the standard curve.
Statistical analysis. Results are expressed as means  SE. Data
were analyzed by one-way ANOVA followed by the Tukey or
Newman-Keuls test. Nonparametric data were analyzed by the Dunn
or Kruskal-Wallis test. P  0.05 was considered significant.
RESULTS
Total renin content, including active renin and prorenin, was
measured in the cell lysate and culture medium. Renin content
was estimated in the presence of an excess of substrate. In the
cell lysate it corresponds to the amount accumulated over 72 h,
and the content in the culture medium corresponds to the
amount accumulated over the last 24 h of the experimental
protocol. The amount of prorenin was calculated from the
difference between the content of total and active renin. The
content of renin was estimated from renin activity, obtained
with an excess of substrate. Figure 1 represents the content of
active and inactive renin in both cell lysate and culture me-
dium. High glucose concentration induced an impressive ele-
vation in the intracellular content of active renin as well as in
the prorenin content compared with the control groups (NG
and M). In contrast, in the culture medium the content of active
renin was similar for the three groups, but the amount of
prorenin was reduced by HG compared with control cells.
Figure 2 shows renin activity expressed as nanograms of
ANG I per milligram protein per hour in the cell lysate and
culture medium. Besides increasing renin content, a high glu-
cose concentration also induced a significant 30-fold increase
in the renin activity measured in the cell lysate compared with
the control and M groups but did not change renin activity in
the culture medium.
The expression of mRNAs for angiotensinogen, cathepsin B,
prorenin, ACE, and AT1 and AT2 receptors was detected in
mesangial cells by RT-PCR (data not shown). After optimiza-
tion of the PCR conditions for each primer pair, specific for
each component, cDNA samples were used to quantify the
mRNAs by real-time PCR. Figure 3 shows a representative
standard curve and amplification curves for ACE in the three
groups. A threshold was determined for each PCR run to match
the logarithmic phase of the curve, and the amount of each
cDNA was estimated from the standard curve. As can be
observed in this representative curve for ACE, the control
samples (NG and M) were closer to the most diluted points
(1:100 and 1:10), whereas the HG samples coincided with the
undiluted point.
Figure 4 shows the relative quantification of mRNAs for all
RAS components. Data are expressed in arbitrary units con-
sidering GAPDH as the internal control. The mRNA expres-
sion levels detected after 72 h of high-glucose exposure were
unchanged for all components except angiotensinogen, 1.8-
fold higher than in the NG group, and mainly ACE mRNA,
which presented a 15-fold increase compared with the NG
group. In addition, the mRNA expression levels of the RAS
enzymes including prorenin, cathepsin B, and ACE were fur-
ther estimated after 24 h of high-glucose exposure. Figure 5
shows that after this shorter period the mRNA expression
Fig. 1. Renin and prorenin content in the cell lysate and culture medium. The
content of renin and prorenin was estimated in the mesangial cell lysate after
72 h of exposure to normal (NG; 10 mM) or high (HG; 30 mM) glucose or
mannitol (M; 30 mM). The content obtained in the culture medium refers to the
amount of renin forms secreted during the last 24 h. Values were estimated
from the amount of ANG I measured by HPLC. Prorenin was activated by
adding 10 l of trypsin (50 g/ml) for 16–18 h at 37°C. Active renin was
evaluated in the absence of trypsin. Values are means  SE of 6 experiments/
group. *P  0.05 vs. control (NG) and the M group.
Fig. 2. Renin activity. Renin activity was obtained by incubating the cell lysate
and culture medium with the renin substrate for 4 h at 37°C. Values were
estimated from the amount of ANG I generated in the absence of trypsin.
Values are means  SE of 6 experiments/group. *P  0.05 vs. NG and M
groups.
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levels for the three enzymes were significantly elevated in the
HG group compared with the NG group.
ANG II concentration in mesangial cells was determined by
ELISA. As shown in Fig. 6, glucose-stimulated cells presented
a significant increase in ANG II generation compared with
control cells. Mannitol-exposed cells also presented an in-
crease in ANG II, but the mean value obtained did not differ
from control cells.
DISCUSSION
Many lines of evidence suggest a role for intrarenally
formed ANG II in the pathogenesis of diabetic nephropathy
(12, 21, 32). It has been shown that glucose and ANG II are
able to increase the synthesis of collagen types I and IV and
other matrix proteins in mesangial cells, as well as to decrease
the levels of proteases involved in matrix degradation, result-
ing in the matrix expansion observed in diabetic nephropathy
(19, 37). It has been shown that increasing glucose concentra-
tions cause proportional increases in ANG II generation in
mesangial cells (38). In the present study, we obtained further
evidence that mesangial cells may contribute to the enhance-
ment of intrarenal ANG II observed in diabetic kidneys.
We have shown that mesangial cells are able to synthesize,
store, and spontaneously secrete both the active and inactive
forms of renin, as previously demonstrated by us in rat and
mouse mesangial cells (4) and by Chansel et al. (10) in human
mesangial cells. Moreover, it was shown that the secretion rate
of active and inactive renin changes in response to the external
stimulus induced by high glucose concentration in the culture
medium. In control and mannitol-stimulated cells, prorenin
was predominant in the culture medium, indicating that under
basal conditions most of the renin secreted is in the inactive
Fig. 3. Representative standard curve and real-time PCR run.
The standard curve was constructed from serial dilutions of
cDNA using angiotensin-converting enzyme (ACE)-specific
primers (1) and representative PCR run for ACE in groups NG
(2), M (3), and HG (4). See text for details.
Fig. 4. Quantitative real-time PCR for renin-angiotensin (AGTN) system
(RAS) components and cathepsin B (CATHEP). Total RNA was isolated from
pooled cells obtained from 4 or 5 culture flasks from each group. The relative
amount of mRNAs was estimated by real-time PCR, normalized by GAPDH
used as endogenous control, and expressed as arbitrary units. Values are
means  SE of 5 experiments/group after 72 h of stimulation with mannitol or
high glucose. *P  0.05 vs. control.
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form, as also described for juxtaglomerular cells and other
renin-secreting cells (9, 15, 18). The reason mesangial cells
secrete large quantities of inactive renin is not known, but the
presence of renin and prorenin receptors in the kidney (29) and
mesangial cells (28) suggests an exciting possibility of auto-
crine and paracrine functions for prorenin and renin secreted by
mesangial cells.
High glucose induced a reduction in renin content in the
culture medium, mainly in prorenin secretion, roughly three
times that observed in control cells, resulting in the accumu-
lation of prorenin in the intracellular compartment. It was
recently demonstrated that the mesangial renin receptor binds
renin and prorenin, and the binding of renin to this receptor, in
human mesangial cells, induced a fourfold increase in the
efficiency of angiotensinogen conversion to ANG I (29) com-
pared with renin in the soluble phase. Moreover, the renin/
prorenin binding to the receptor would not be detected in the
culture medium but in the cell lysate fraction. Whether the
increased prorenin content in the intracellular compartment
observed in the present study was a result of reduced secretion
and/or a binding to the receptor deserves further investigation.
In addition, intracellular prorenin accumulation was also a
result of increased prorenin gene transcription, observed after a
short period of high-glucose stimulation. Actually, one of the
most important events observed in the present study was an
impressive rise in intracellular renin content and activity in-
duced by high-glucose exposure, suggesting that the accumu-
lated prorenin was converted to active renin inside the cell, and
thus high glucose also induced an increase in the rate of
prorenin-to-renin conversion. This result is in contrast to that
recently described by Singh and co-workers (38). They found
that renin activity, measured as ANG I generation in the
presence of an excess of angiotensinogen, was not altered by
high glucose. We have no explanation for this discrepancy, but
maybe some differences between the protocols used to measure
renin activity would be considered. For instance, the aforemen-
tioned study does not mention whether the protease inhibitors
were added to the renin assay, as in the present study, and this
is particularly important because renin appears to be rapidly
inactivated in vitro and probably by proteases (13).
The conversion of prorenin to active renin results from the
proteolytic cleavage of 43 amino acids from the pro-segment of
prorenin. Although many enzymes have been implicated in this
mechanism, cathepsin B has been suggested to be the primary
one involved in the activation of prorenin in vivo (27). The
presence of cathepsin B-like activity was recently demon-
strated in rat mesangial cells, in parallel to its ability to
hydrolyze prorenin (1), making this enzyme a potential candi-
date involved in the conversion of prorenin to active renin in
mesangial cells. We found a significant increase in cathepsin B
mRNA expression levels after 24 h of high-glucose exposure,
possibly indicating that the increase in the conversion of
prorenin to active renin induced by high glucose was, at least
initially, mediated by cathepsin B. On the other hand, cathepsin
B mRNA returned to control levels after the more prolonged
period of 72 h of glucose stimulation. Actually, previous
reports have shown that the diabetic milieu is mostly associated
with a decrease in the degradative enzymes, including cathep-
sin B, in glomeruli and mesangial cells (22, 23, 39). Taken
together, these data raise the possibility that glucose may
interfere with cathepsin B expression through a time-dependent
pathway, initially stimulating and then suppressing cathepsin B
gene transcription.
Similar to cathepsin B mRNA expression, high glucose
induced an initial increase in prorenin mRNA, detected after
24 h, with a return to control levels after 72 h of glucose
exposure, suggesting that renin synthesis by mesangial cells is
probably subjected to the usual negative feedback control
Fig. 5. Quantitative real-time PCR for pro-
renin, cathepsin B, and ACE. mRNA expres-
sion levels for the enzymes were quantified
after a shorter period of glucose incubation
(24 h) and compared with 72 h of incubation.
Quantification was performed by real-time
PCR using GAPDH as the endogenous con-
trol. Values are means  SE of 5 experi-
ments/group expressed in arbitrary units.
*P  0.05 vs. NG group.
Fig. 6. Intracellular ANG II concentration. ANG II was measured by ELISA in
the cell lysate after 72 h of exposure to normal or high glucose or mannitol.
Values are means  SE of 5 experiments. *P  0.05 vs. NG group.
F1043GLUCOSE STIMULATES ANGIOTENSIN SYNTHESIS IN MESANGIAL CELLS
AJP-Renal Physiol • VOL 286 • JUNE 2004 • www.ajprenal.org
induced by ANG II as classically observed in juxtaglomerular
cells (26).
In contrast to time-dependent upregulation of prorenin and
cathepsin B gene transcription, the expression levels of ACE
mRNA were significantly elevated after both 24 and 72 h of
high-glucose stimulation, suggesting that ACE is probably
involved in the increased mesangial ANG II generation by
glucose. However, whether ACE gene transcription is influ-
enced by high glucose and/or by ANG I concentration deserves
additional investigation.
High glucose induced an upregulation of angiotensinogen
gene expression detected after 72 h. Singh et al. (38) recently
demonstrated that mesangial cells incubated in high-glucose
media increased both angiotensinogen mRNA and protein
levels. Taken together, these data suggest that, in parallel to
increased renin activity, high glucose also increased the avail-
ability of the renin substrate.
The results showed that mesangial cells in culture are able to
constitutively express mRNA for both AT1 and AT2 receptors,
as also previously demonstrated (6, 11, 20, 35). In contrast to
intracellular components, high glucose did not change mRNA
expression levels for AT1 or AT2 receptors. Conflicting results
have been reported concerning the effect of glucose or diabetes
on the expression of ANG II receptors in kidney cells. Down-
regulation of the AT1 receptor has been demonstrated in
glomeruli and proximal tubules of diabetic rats (7, 30, 40), as
well as in mesangial cells chronically incubated in culture
medium containing high glucose levels (2). In contrast, Choui-
nard and co-workers (11) recently demonstrated that high
glucose did not modify AT1 mRNA expression in mesangial
cells but increased the expression of AT2 receptors. On the
other hand, the absence of changes in ANG II receptor mRNA
observed in the present study does not rule out the possibility
of an upregulation of gene transcription during shorter periods
of glucose stimulation. Finally, it is important to reflect on the
possibility that ANG II may not leave the cells to induce its
effects. Previous data from our laboratory (unpublished obser-
vations) showed ANG II immunostaining in the nucleus of
mesangial cells, which was strongly increased after exposure to
high glucose levels. ANG II accumulation inside the nucleus
has been found in other tissues, including myocardium, brain,
smooth muscle, and adrenal glands (8, 14, 32). The presence of
ANG II inside the nucleus may represent an exciting mecha-
nism involved in the well-known effects of ANG II-inducing
gene expression, particularly those involved in cell growth,
metabolism, and synthesis of extracellular matrix components,
manifestations that are typical of diabetic nephropathy.
In summary, the present study showed a significant increase
in ANG II generation in mesangial cells exposed to a high
glucose concentration. The results suggest that the mechanisms
involved in the upregulation of mesangial ANG II primarily
include an increase in intracellular renin activity, which re-
sulted from at least three mechanisms, i.e., a time-dependent
stimulation of prorenin gene transcription, a reduction in pro-
renin secretion, and an increase in the rate of prorenin conver-
sion to active renin, probably mediated by cathepsin B. The
increased renin activity was paralleled by a rise in angio-
tensinogen gene expression, indicating availability of the sub-
strate to renin. In contrast to time-dependent upregulation of
prorenin and cathepsin B gene transcription, the expression
levels of ACE mRNA were significantly elevated after both 24
and 72 h of high-glucose stimulation, indicating that ACE
upregulation is probably necessary to increase ANG II synthe-
sis. The mRNA levels for ANG II receptors were unchanged,
at least after 72 h of exposure to glucose, suggesting that ANG
II production by mesangial cells under glucose stimulation may
serve as an intracrine action, thus directly mediating the pro-
liferative and inflammatory effects of ANG II, with consequent
cell proliferation, matrix expansion, and inflammation contrib-
uting to the glomerular sclerosis observed in diabetic nephrop-
athy.
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